Life Science Analytics Market Projected to Reach $61.94 Billion by 2029, Driven by Big Data Adoption and Value-Based Care Trends
According to the latest report “Life Science Analytics Market by Type (Descriptive, Prescriptive, Predictive), Service (Analytics), Application (Drug Discovery, Clinical Trials, Real-World Evidence, Market Access, Sales & Marketing, Drug Safety), End User (Pharmaceutical, Medical Devices), and Region – Global Forecast to 2029,” the global life science analytics market is expected to grow from USD 35.69 billion in 2024 to USD 61.94 billion by 2029, at a CAGR of 11.7% during the forecast period.
👉 Explore 455 market data tables, 54 figures, and 385 pages of in-depth analysis in the complete report:
View the Full Report
Market Drivers & Opportunities
The rapid growth of the life science analytics market can be attributed to several factors, including:
- Increasing emphasis on value-based care and data-driven decision-making.
- Rising demand for big data analytics to accelerate R&D and drug development.
- Widespread adoption of cloud-based analytics solutions.
- Growing role of analytics in personalized and precision medicine.
However, challenges such as data integration complexities, a shortage of skilled analytical professionals, and reluctance to adopt analytics technologies in emerging economies could hinder market growth to some extent.
Managed Services Lead the Life Science Analytics Services Segment
By service type, the market is segmented into managed services and professional services. As of 2023, the managed services segment holds the largest market share, driven by:
- Increasing need for advanced insights and cost-effective drug development.
- Technological advancements enhancing data processing capabilities.
- Demand for ongoing strategic support through outsourced analytics and consulting.
Notable Industry Move: In May 2023, SAS Institute (US) partnered with HTEC (US) to deliver strategic analytics consulting services across life sciences, healthcare, and logistics.
Research & Development Emerges as the Leading Application
By application, the market covers:
- Research & Development (R&D)
- Commercial Analytics
- Regulatory Compliance
- Manufacturing & Supply Chain Optimization
- Drug Safety & Pharmacovigilance
R&D holds the largest market share in 2023, largely due to the increasing use of advanced data analytics and AI-driven insights to accelerate drug discovery, optimize clinical trials, and improve research accuracy. Other contributing factors include:
- Rising R&D investments in pharma and biopharma.
- Growing number of patent expiries and shrinking drug pipelines.
- Increasing focus on personalized medicine and precision therapeutics.
Asia Pacific Expected to See Fastest Growth
Regionally, the life science analytics market spans:
- North America
- Europe
- Asia Pacific
- Latin America
- Middle East & Africa
Asia Pacific is projected to register the highest growth rate during the forecast period, supported by:
- Rising adoption of advanced technologies like AI, ML, and automation.
- Increasing foreign investments from European and North American pharmaceutical companies.
- Strong presence of leading academic institutions and research hubs driving innovation.
Key Players Shaping the Market
Leading players in the life science analytics market include:
- Oracle (US)
- Merative (formerly IBM) (US)
- SAS Institute (US)
- Accenture (Ireland)
- IQVIA (US)
- Cognizant (US)
- Wipro (India)
- Veradigm (US)
- Optum (UnitedHealth Group) (US)
- Microsoft (US)
- MaxisIT (US)
- ExlService Holdings (US)
- Inovalon (US)
- CitiusTech (US)
- Saama (US)
- Axtria (US)
- Clarivate (UK)
- ThoughtSphere (US)
- ThoughtSpot (US)
- Salesforce (US)
- Google LLC (US)
- Amazon Web Services (US)
- Veeva Systems (US)
- Elsevier (Netherlands)
- Komodo Health, Inc. (US)
These companies continue to focus on acquisitions, partnerships, product innovations, and regional expansions to strengthen their market position.